Close Menu

NEW YORK – The National Institutes of Health in collaboration with the Biomedical Advanced Research and Development Authority (BARDA) announced on Wednesday six Rapid Acceleration of Diagnostics (RADx) initiative contracts totaling $98.35 million.

The awards support clinical validation, manufacturing, and scale up of point-of-care and other novel test approaches that provide new modes of sample collection, processing, and return of results, the agency said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Bloomberg reports the US Centers for Medicare & Medicaid Services sent Orig3n a letter saying it has not corrected lab issues uncovered in an earlier inspection.

In an editorial at BMJ Opinion, two genetic counselors call for an increased focus on post-test patient care.

A new survey finds people in the US are getting their COVID-19 test results back faster, but not fast enough to help some viral control measures, NPR reports.

In PLOS this week: genomic analysis of malaria parasites in Ethiopia, loci linked to childhood BMI, and more.